Edition:
United States

Carmat SA (ALCAR.PA)

ALCAR.PA on Paris Stock Exchange

23.13EUR
--
Change (% chg)

-- (--)
Prev Close
€23.13
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,587
52-wk High
€40.06
52-wk Low
€23.04

Select another date:

Wed, Jul 5 2017

Photo

French implant maker Carmat pins hopes on low energy heart

PARIS Artificial heart maker Carmat is hoping a more energy-efficient implant and the appointment of a production chief can help it overcome recent failures at the French firm.

Carmat buoyed by approval to resume artificial heart trial

Artificial heart maker Carmat has obtained approval from France's national drugs agency (ANSM) to resume a heart implant trial, sending the company's shares more than one fifth higher on Wednesday.

UPDATE 2-Carmat buoyed by approval to resume artificial heart trial

May 3 Artificial heart maker Carmat has obtained approval from France's national drugs agency (ANSM) to resume a heart implant trial, sending the company's shares more than one fifth higher on Wednesday.

Carmat gets approval to resume artificial heart implants trial

May 2 Artificial heart maker Carmat has obtained approval from France's national drugs agency (ANSM) to resume heart implant trials, the company said on Tuesday.

Select another date: